As EGFR expression in anal carcinoma is observed in a high number of patients (about 80–90% of cases)4, 5, 6, anti-EGFR drugs have been studied for the treatment of SCAC, showing anti-tumoral activity7, 8, 9, 10. Here, EGFR is linked to anal carcinoma.